Aim of the work: Descriptions of the body composition parameters and metabolism in systemic lupus erythematosus (SLE) patients are limited. The aim of the present work was to assess the body composition factors and basal metabolic rate (BMR) in Iranian SLE patients and to study its relation to disease activity. Patients and methods: Seventy-four female SLE patients and 76 matched controls were included in the present study. The body mass index (BMI), body fat (BF), visceral fat (VF), body muscle (BM) and basal metabolic rate (BMR) were measured using BIA (bioelectrical impedance analysis). The international physical activity questionnaire (IPAQ) was used to assess physical activity. SLE disease activity index (SLEDAI) was assessed for all the patients. Results: The mean age of the patients was 38.5 ± 10.1 years with a median disease duration of 7.5 years. The median SLEDAI was 4. Body composition factors (BMI, BF, VF, and BM) were not significantly different between the patients and their controls. The BMR in SLE patients was significantly lower (1328.4 ± 154.6 kcal/day) than the controls (1400.4 ± 200.4 kcal/day) (p = 0.01). No differences have been found in body composition parameters and BMR between the SLE patients with high and low SLEDAI or daily corticosteroid dose. There was no significant correlation between the SLEDAI and any of the studied parameters except for a negative association with age (r = À0.3, p = 0.03). Conclusion: SLE women have a significantly lower BMR compared to their controls. No significant differences have been observed regarding BMI, BF, BM and VF between the groups.
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissues [1] . Early coronary heart disease has appeared as a main cause of morbidity in SLE patients. In addition, cardiovascular induced mortality has been increased in these patients compared with the general population [2] [3] [4] [5] [6] . Increased cardiovascular events can be explained in part by an increased prevalence of cardiovascular disease (CVD) risk factors such as metabolic syndrome (MetS) and its components [6] . Improved control of SLE disease activity could help in minimizing the development of irreversible damage [7] .
The amount and distribution of body fat and lean mass have an important impact on health [8] . In SLE, disproportionate adiposity in abdominal region as a key-feature of MetS together with proinflammatory and prothrombotic state contributes to atherosclerosis [1] [2] [3] . An association of BMI with dyslipidemia and decreased quality of life in SLE patients has been reported. QoL. Even though its role in disease activity is not clear, obesity was associated with SLE damage accrual [9] . Effective management of MetS would help control SLE activity, damage, and the future development of cardiovascular events [10] . http 
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Basal metabolic rate (BMR) is the most important indicator of human metabolism and its abnormalities have been linked to undesirable health outcomes [16] . The BMR reflects a combination of cardiopulmonary function and lean body mass resulting from regular physical activity [17] . The BMR is referred to as the minimal rate of metabolism required to support basic body functions. It is well known that individual BMR varies greatly, even when correcting for body weight, fat content, and thyroid hormone levels, but the mechanistic determinants of this phenomenon remain unknown [18] . There was no difference in weight gain between adults with low and high BMR, implying that habitual differences in food intake or activity may counterbalance variations in BMR as a risk factor for weight gain [19] . The interindividual variation in BMR in humans could be primarily explained by differences in mitochondrial oxygen affinity [18] .
The BMR is high in rheumatoid arthritis (RA) patients due to hypercatabolism caused by systemic inflammation and cigarette smoking has been associated with a further increase [16] . BMR is closely associated with bone mineral density (BMD) in elderly persons and may be a novel target for interventions aimed at preventing the age-related decline in BMD [17] .
Few studies have assessed the relationship of body composition and disease activity in SLE patients [2, [20] [21] [22] [23] . Thus, the aim of the present work was to assess the body composition factors and basal metabolic rate (BMR) in Iranian SLE patients compared to healthy control and to study its relation to disease activity.
Patients and methods

Participants
Between August and November 2015, 74 adult females aged 20-65 years diagnosed according to Systemic Lupus International Collaborating Clinics classification criteria for SLE [24] were recruited from the rheumatology clinic at Hafez Hospital in Shiraz. Patients exclusion criteria were pregnancy, lactation, ischemic heart disease and reduced renal function (serum creatinine >2.5 mg/dl). The control group consisted of 76 healthy female who were matched in age, body mass index (BMI) and physical activity level. Interpretation of BMI was as follows: <18.5 kg/m 2 (underweight), 18.5-24.9 (normal), (25-29.9) (overweight), and values P30 (obese). This study was done in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines and was approved by the Ethics Committee of Ahvaz University of Medical Sciences. All the participants completed the written informed consent.
Variables
Demographic data, health habits (smoking status), physical activity, disease duration and medications used were recorded in the SLE patients. Disease activity was assessed with the systemic lupus erythematosus disease activity index (SLEDAI) [25] . Patients were categorized according to the disease activity into two groups; <6 and P6 [26] . Blood and urine samples were collected in order to calculate SLE disease activity required tests including complete blood count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), anti-DNA antibody titer, C3 and C4 level and urinalysis. Corticosteroid use (prednisone) was categorized as follows: low (67.5 mg/day), medium (7.5-30 mg/day) and high dose (>30 mg/d) [27] .
In all participants, the whole assessments were performed during the morning visit to balance the circadian alterations. Height (cm) and weight (kg) were measured in standing position with light clothes without shoes. Percentage of body fat and visceral fat, fat free mass (FFM) (kg) and resting basal metabolic rate (BMR) were measured by bioelectrical impedance analysis (BIA), using an Omron BF-511Body Composition Monitor. Taking measurements was avoided under the following conditions: immediately after vigorous exercise, after a bath or sauna, after drinking alcohol or a large amount of water or after a meal (at least 2 h). In order to make a good match between the patients and controls, both premenopausal and postmenopausal subjects were included in the two groups of the study for omitting the confounding effect of menstrual cycle on BMR.
Because of the necessity of considering physical activity level in both groups of SLE patients and healthy controls, the participants were asked to report their daily physical activity by filling a questionnaire; the international physical activity questionnaire (IPAQ) [28] . There are three levels of physical activity according to IPAC questionnaire: inactive, minimally active and HEPA active (health enhancing physical activity; a high active category).
Statistics
Data were analyzed using SPSS 18 (SPSS Inc., Chicago, IL) statistical software package. All the data were assessed for normality of distribution, using the Kolmogorov-Smirnov test. Results were presented as mean ± standard deviation. To compare variables, independent sample t test and Mann-Whitney U test were used. The correlations were calculated by the Spearman correlation test and variables with significant coefficients were tested again in backward multivariate regression model. A p-value <0.05 was considered significant.
Results
Seventy-four SLE patients were enrolled in this study. Demographic characteristics, clinical and laboratory features and medications used by the SLE patients are presented Table 1 . According to the IPAQ, all participants were categorized as inactive to minimally active and none were HEPA active. The comparison of age, BMI, body composition parameters and BMR in patients and control is shown in Table 2 . The BMR was significantly lower in SLE Table 3 . Differences based on daily corticosteroid dosage 67.5 and >7.5 mg/day are shown in Table 4 . Nine patients (12.2%) did not receive corticosteroids. In addition no significant differences were seen in body composition parameters according to presence and absence of nephritis, arthritis, positive DS-DNA and hypocomplementemia.
The correlations between SLE disease activity with the age, body composition parameters, BMR and corticosteroid consumption are shown in Table 5 The relation of BMR with the studied parameters remained non-significant even after adjusting for age (p = 0.19), BMI (p = 0.12), physical activity (p = 0.36) and menopause status (p = 0.47) as confounding factors using linear regression.
Discussion
In the present work, the body composition factors and BMR were assessed in Iranian SLE patients and their relation to disease activity was studied. As fat mass (FM), FFM and distribution of fat vary among different ethnic groups; we aimed to assess this trend in Iranian patients. No difference was found in body composition parameters (BMI, BM and BF), BMR and daily corticosteroids dosage in the patients based on their disease activity. This result implies that the disease activity has a limited effect on the metabolism and body composition of SLE patients, while younger patients were more active. The main finding of this study is that the BMR in SLE patients was significantly lower than in the control. To the best of our knowledge, no similar finding has been previously reported. However BMI, FM and FFM were not significantly different between the patients and control which argues against the observed lower BMR in the patients. Furthermore, neither physical activity nor low FFM accounted for patients' lower BMRs. A possible explanation relates to the complicated disease characteristics including the inflammatory burden of lupus itself as well as therapy with corticosteroids. Most patients in this study were on low to medium steroid dose, however, prolonged treatment contributes to net protein catabolism and reduced muscle mass [22] . According to previous studies increased FM and reduced lean body mass is prevalent in SLE patients [22, 23] . Thus the lower BMR could attribute to the compensatory effect of reduced FFM with the aim of preserving normal weight and body composition balance. The BMR in the control (1400.44 ± 200.35 kcal/day) was comparable to that reported for Tehranian women (1410 ± 123 kcal/day) [29] .
The results of one study done by Lilleby et al. showed that in childhood-onset SLE patients body fat mass was higher and lean body mass was lower than in healthy controls. Also corticosteroid consumption was an unrelated predicator of increased FM [20] . Based on the findings of another study that were consistent with our results, no significant differences were found in BMI or total FM of the SLE patients and controls. Furthermore no significant correlation was seen between disease duration, corticosteroid dose, and fat and lean body mass in SLE patients [14] . Regarding the effects of corticosteroid therapy on body composition in SLE patients, in contrast to the present work, a significant negative effect of corticosteroids on FM and FFM has been reported [22] . In terms of disease activity influence on body composition, based on the results of the study performed in pre-menopausal women with SLE, disease activity was correlated with changes in body composition, as higher disease activity was associated with higher BMI and higher FM [23] . This is the first study to report the BMR in SLE patients. A previous study was conducted in fibromyalgia and the BMR was lower in the patients compared to the control [30] .
Our study has potential limitations. As this is an observational cross-sectional type of research we must be cautious in extrapolating causal effects from the results. We did not evaluate the dietary intake of patients as a known risk factor for altered metabolism. As BMR might be a better indicator than BMI for clinical evaluation and following response in RA patients, this finding in lupus patients deserves further research. Cytokine levels, inflammatory markers and adipocytokines (leptin, adiponectin, visfatin) which all could affect BMR have not been measured in our work. Assessment of endocrine status including thyroid hormones, sex hormones and insulin like growth factors would also be helpful in interpreting the altered metabolism seen in these patients. In addition correlation of parameters like anti-DNA titer and complement level with body composition would be interesting.
In conclusion, women with SLE have a significantly lower BMR; however, no significant differences have been observed in patients' BMI, BF, BM, VF compared with healthy individuals. Presumably, consuming immunomodulatory medications, inflammatory burden of the disease might contribute to the altered metabolism seen in these patients.
